Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


04.03.2019

3 Aliment Pharmacol Ther
1 Dig Dis
3 Dig Dis Sci
1 Gut
2 Inflamm Bowel Dis
10 J Crohns Colitis
1 JAMA
1 Mediators Inflamm
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. GIBSON DJ, Ward MG
    Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy-early promise but more data needed.
    Aliment Pharmacol Ther. 2019;49:816-817.
    PubMed     Text format    

  2. BOUGUEN G, Siproudhis L
    Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy - early promise but more data needed. Authors' reply.
    Aliment Pharmacol Ther. 2019;49:817-818.
    PubMed     Text format    

  3. BANK S, Julsgaard M, Abed OK, Burisch J, et al
    Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2019 Feb 27. doi: 10.1111/apt.15187.
    PubMed     Text format     Abstract available


    Dig Dis

  4. EVEN DAR R, Mazor Y, Karban A, Ish-Shalom S, et al
    Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
    Dig Dis. 2019 Feb 21:1-7. doi: 10.1159/000496935.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. KOSLOWSKY B, Sadeh C, Grisaru-Granovsky S, Miskin H, et al
    Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05555.
    PubMed     Text format     Abstract available

  6. COHEN-MEKELBURG S, Schneider Y, Gold S, Ghosh G, et al
    Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05554.
    PubMed     Text format     Abstract available

  7. CUSHING KC, Kordbacheh H, Gee MS, Kambadakone A, et al
    CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis Patients.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05520.
    PubMed     Text format     Abstract available


    Gut

  8. MOULTON CD, Norton C, Powell N, Mohamedali Z, et al
    Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation?
    Gut. 2019 Feb 26. pii: gutjnl-2019-318444. doi: 10.1136/gutjnl-2019-318444.
    PubMed     Text format    


    Inflamm Bowel Dis

  9. ADHATAMSOONTRA P, Silverman AL, Doria NA, Alsulami N, et al
    A Clouded Picture: Online Resources in IBD Lack Patient-Centered Language.
    Inflamm Bowel Dis. 2018;24:e1.
    PubMed     Text format    

  10. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
    Inflamm Bowel Dis. 2019 Mar 1. pii: 5368148. doi: 10.1093.
    PubMed     Text format    


    J Crohns Colitis

  11. KEITA AV, Lindqvist CM, Ost A, Magana CDL, et al
    Gut Barrier Dysfunction-A Primary Defect in Twins with Crohn's Disease Predominantly Caused by Genetic Predisposition.
    J Crohns Colitis. 2018;12:1200-1209.
    PubMed     Text format     Abstract available

  12. ICHIKAWA R, Lamb CA, Eastham-Anderson J, Scherl A, et al
    AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation.
    J Crohns Colitis. 2018;12:1191-1199.
    PubMed     Text format     Abstract available

  13. RUEMMELE FM, Rosh J, Faubion WA, Dubinsky MC, et al
    Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2.
    J Crohns Colitis. 2018;12:1249-1254.
    PubMed     Text format     Abstract available

  14. SHEN W, Li Y, Cao L, Cai X, et al
    Decreased Expression of Prox1 Is Associated With Postoperative Recurrence in Crohn's Disease.
    J Crohns Colitis. 2018;12:1210-1218.
    PubMed     Text format     Abstract available

  15. BOSSUYT P, Louis E, Mary JY, Vermeire S, et al
    Defining Endoscopic Remission in Ileocolonic Crohn's Disease: Let's Start from Scratch.
    J Crohns Colitis. 2018;12:1245-1248.
    PubMed     Text format     Abstract available

  16. THIERRY ML, Rousseau H, Pouillon L, Girard-Gavanier M, et al
    Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease.
    J Crohns Colitis. 2018;12:1180-1190.
    PubMed     Text format     Abstract available

  17. VISVANATHAN S, Baum P, Salas A, Vinisko R, et al
    Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study.
    J Crohns Colitis. 2018;12:1170-1179.
    PubMed     Text format     Abstract available

  18. PANES J, Lindsay JO, Teich N, Lindgren S, et al
    Five-year Safety Data From OPUS, A European Observational Safety Registry For Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade(R)] Or Conventional Therapy.
    J Crohns Colitis. 2019 Feb 27. pii: 5365571. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. TORRES J, Ellul P, Langhorst J, Mikocka-Walus A, et al
    European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Mar 1. pii: 5367297. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. COFFEY CJ, Kiernan MG, Sahebally SM, Jarrar A, et al
    Inclusion of the Mesentery in Ileocolic Resection for Crohn's Disease is Associated With Reduced Surgical Recurrence.
    J Crohns Colitis. 2018;12:1139-1150.
    PubMed     Text format     Abstract available


    JAMA

  21. WALKER GJ, Harrison JW, Heap GA, Voskuil MD, et al
    Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
    JAMA. 2019;321:773-785.
    PubMed     Text format     Abstract available


    Mediators Inflamm

  22. NING L, Lou X, Zhang F, Xu G, et al
    Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:2624941.
    PubMed     Text format     Abstract available


    PLoS One

  23. MOTOYA S, Watanabe K, Ogata H, Kanai T, et al
    Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.
    PLoS One. 2019;14:e0212989.
    PubMed     Text format     Abstract available

  24. GONZALEZ-LOPEZ E, Kawasawa-Imamura Y, Zhang L, Huang X, et al
    A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.
    PLoS One. 2019;14:e0210175.
    PubMed     Text format     Abstract available

  25. CHOI EJ, Lee HJ, Kim WJ, Han KI, et al
    Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model.
    PLoS One. 2019;14:e0210854.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: